PGD2

Pgd2 is a lipid of Fatty Acyls (FA) class. Pgd2 is associated with abnormalities such as Inflammatory disorder, Pleurisy, Rhinitis, Dehydration and Pneumonia. The involved functions are known as antagonists, fat cell differentiation, Phosphorylation, Process and Gene Expression. Pgd2 often locates in Cell surface, Body tissue, Extracellular, Bone Marrow and Membrane. The associated genes with PGD2 are oxytocin, 1-desamino-(O-Et-Tyr)(2)-, P4HTM gene, PTGS2 gene, PTGDS gene and IL3 gene. The related lipids are 15-deoxyprostaglandin J2, Nonesterified Fatty Acids, Lipopolysaccharides, Steroids and Liposomes. The related experimental models are Knock-out and Rodent Model.

Cross Reference

Introduction

To understand associated biological information of PGD2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with PGD2?

PGD2 is suspected in Asthma, Dehydration, Allergic rhinitis NOS, Rhinitis, Infertility, Pneumonia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with PGD2

MeSH term MeSH ID Detail
Liver Cirrhosis, Experimental D008106 36 associated lipids
Liver Cirrhosis, Biliary D008105 12 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Leukodystrophy, Globoid Cell D007965 6 associated lipids
Leukemia, Myeloid D007951 52 associated lipids
Leukemia, Megakaryoblastic, Acute D007947 7 associated lipids
Leukemia, Experimental D007942 42 associated lipids
Leukemia P388 D007941 43 associated lipids
Leukemia D007938 74 associated lipids
Leiomyoma D007889 8 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Inflammation D007249 119 associated lipids
Hypothermia D007035 19 associated lipids
Hypotension D007022 41 associated lipids
Hypertension, Pulmonary D006976 32 associated lipids
Hypertension D006973 115 associated lipids
Hypersensitivity, Immediate D006969 14 associated lipids
Hypersensitivity, Delayed D006968 43 associated lipids
Hypersensitivity D006967 22 associated lipids
Hyperlipoproteinemia Type IV D006953 6 associated lipids
Hyperlipoproteinemias D006951 15 associated lipids
Hyperlipidemias D006949 73 associated lipids
Hyperemia D006940 25 associated lipids
Hyperlipoproteinemia Type II D006938 22 associated lipids
Hypercholesterolemia D006937 91 associated lipids
Hypercalcemia D006934 13 associated lipids
Hyperalgesia D006930 42 associated lipids
HIV Seropositivity D006679 15 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Gastrointestinal Hemorrhage D006471 27 associated lipids
Hemolysis D006461 131 associated lipids
Hematoma D006406 5 associated lipids
Headache D006261 4 associated lipids
Rhinitis, Allergic, Seasonal D006255 7 associated lipids
Goiter D006042 4 associated lipids
Glioma D005910 112 associated lipids
Gastroesophageal Reflux D005764 10 associated lipids
Folliculitis D005499 7 associated lipids
Fibrosis D005355 23 associated lipids
Fever D005334 35 associated lipids
Erythema D004890 22 associated lipids
Epilepsy, Tonic-Clonic D004830 2 associated lipids
Encephalomyelitis, Autoimmune, Experimental D004681 26 associated lipids
Encephalitis D004660 15 associated lipids
Edema D004487 152 associated lipids
Dyskinesia, Drug-Induced D004409 15 associated lipids
Down Syndrome D004314 18 associated lipids
Dirofilariasis D004184 3 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Dermatitis, Atopic D003876 19 associated lipids
Drug Eruptions D003875 30 associated lipids
Dehydration D003681 11 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Cryptorchidism D003456 2 associated lipids
Cryptococcosis D003453 3 associated lipids
Cough D003371 19 associated lipids
Coronary Disease D003327 70 associated lipids
Coronary Artery Disease D003324 47 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Colitis D003092 69 associated lipids
Chondrosarcoma D002813 9 associated lipids
Cholangitis D002761 3 associated lipids
Brain Ischemia D002545 89 associated lipids
Cell Transformation, Viral D002472 26 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Cataract D002386 34 associated lipids
Catalepsy D002375 30 associated lipids
Carotid Artery Thrombosis D002341 7 associated lipids
Carcinoma, Renal Cell D002292 12 associated lipids
Carcinoma, Non-Small-Cell Lung D002289 72 associated lipids
Bronchial Spasm D001986 18 associated lipids
Brain Damage, Chronic D001925 6 associated lipids
Body Weight D001835 333 associated lipids
Blood Platelet Disorders D001791 12 associated lipids
Blister D001768 16 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Astrocytoma D001254 15 associated lipids
Asthma D001249 52 associated lipids
Ascariasis D001196 3 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Arthritis D001168 41 associated lipids
Arteriosclerosis D001161 86 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Anaphylaxis D000707 35 associated lipids
Anal Gland Neoplasms D000694 1 associated lipids
Alzheimer Disease D000544 76 associated lipids
Adenocarcinoma D000230 166 associated lipids
Actinobacillus Infections D000189 4 associated lipids
Per page 10 20 50 100 | Total 189

PubChem Associated disorders and diseases

What pathways are associated with PGD2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with PGD2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with PGD2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with PGD2?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with PGD2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with PGD2?

Knock-out

Knock-out are used in the study 'Multiple roles of the prostaglandin D2 signaling pathway in reproduction.' (Rossitto M et al., 2015).

Rodent Model

Rodent Model are used in the study 'PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation.' (Kong D et al., 2016).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with PGD2

Download all related citations
Per page 10 20 50 100 | Total 3138
Authors Title Published Journal PubMed Link
Yamaguchi K and Hama H Separation of periventricular dopaminergic and alpha-adrenergic systems from the vasopressin-secreting mechanisms activated by prostaglandin D2. 1991 Brain Res. pmid:1665382
Giles H et al. A comparative study of the prostanoid receptor profile of 9 alpha 11 beta-prostaglandin F2 and prostaglandin D2. 1991 Br. J. Pharmacol. pmid:1665742
Georgitis JW et al. Nasal inflammatory mediator release in ragweed allergic rhinitis: correlation with cellular influx into nasal secretions. 1991 Int. Arch. Allergy Appl. Immunol. pmid:1666629
Takayanagi I et al. Effects of aging on alpha 2-adrenoceptor mechanisms in isolated guinea-pig tracheal preparations. 1991 Eur. J. Pharmacol. pmid:1674919
Goerg KJ et al. Antisecretory effect of prostaglandin D2 in rat colon in vitro: action sites. 1991 Am. J. Physiol. pmid:1676243
Keenan CM and Rangachari PK Contrasting effects of PGE2 and PGD2: ion transport in the canine proximal colon. 1991 Am. J. Physiol. pmid:2003610
Roberts LJ and Oates JA Biochemical diagnosis of systemic mast cell disorders. 1991 J. Invest. Dermatol. pmid:16799604
Sinzinger H et al. Platelet lipoxygenase defect (Wien-Penzing defect) in two patients with myocardial infarction. 1991 Am. J. Hematol. pmid:1899965
Brodsky L et al. Arachidonic acid metabolites in middle ear effusions of children. 1991 Ann. Otol. Rhinol. Laryngol. pmid:1648326
Tasaki Y et al. Prostaglandin D2 metabolite stimulates collagen synthesis by human osteoblasts during calcification. 1991 Prostaglandins pmid:1871375
Vesin MF et al. Preferential synthesis of prostaglandin D2 by neurons and prostaglandin E2 by fibroblasts and nonneuronal cells in chick dorsal root ganglia. 1991 J. Neurochem. pmid:2051162
Fukushima M [Prostaglandins and cell proliferation]. 1991 Tanpakushitsu Kakusan Koso pmid:2024021
Hori T et al. Prostaglandins antagonize fibroblast proliferation stimulated by tumor necrosis factor. 1991 Biochem. Biophys. Res. Commun. pmid:1993070
Morii H and Watanabe Y Solubilization of prostaglandin D2 binding protein from porcine temporal cortex. 1991 Biochem. Biophys. Res. Commun. pmid:1989614
Dore-Duffy P et al. Cerebrospinal fluid eicosanoid levels: endogenous PGD2 and LTC4 synthesis by antigen-presenting cells that migrate to the central nervous system. 1991 Neurology pmid:1992386
Wenzel SE et al. Bronchoalveolar lavage fluid mediator levels 5 minutes after allergen challenge in atopic subjects with asthma: relationship to the development of late asthmatic responses. 1991 J. Allergy Clin. Immunol. pmid:1993813
Norman P et al. BAY u3405 is a potent and competitive antagonist of U46619, PGD2 and 9 alpha, 11 beta PGF2 alpha-induced contractions of airway smooth muscle. 1991 Ann. N. Y. Acad. Sci. pmid:1952564
Vesin MF and Droz B Biosynthesis of prostaglandins D2 and E2 in chick dorsal root ganglion during development. 1991 J. Neurochem. pmid:1904909
Shiozaki M et al. Synthesis of 2-deoxy-2-[(2,2-difluoro-3-hydroxytetradecanoyl)amino]-3-O- [(R)-3-(tetradecanoyloxy)tetradecanoyl]-D-glucopyranose 4-phosphate. 1991 J. Med. Chem. pmid:1875354
Inoue M et al. Interactions between brain acetylcholine and prostaglandins in control of vasopressin release. 1991 Am. J. Physiol. pmid:1877699
Francis HP et al. BAY u3405 an antagonist of thromboxane A2- and prostaglandin D2-induced bronchoconstriction in the guinea-pig. 1991 Br. J. Pharmacol. pmid:1797323
Jongejan R et al. Effect of epithelial denudation, inflammatory mediators and mast cell activation on the sensitivity of isolated human airways to methacholine. 1991 Eur. J. Pharmacol. pmid:1800116
Raphael GD et al. The pathophysiology of rhinitis. V. Sources of protein in allergen-induced nasal secretions. 1991 J. Allergy Clin. Immunol. pmid:1712803
Massey WA et al. Human uterine mast cells. Isolation, purification, characterization, ultrastructure, and pharmacology. 1991 J. Immunol. pmid:1715365
Butchers PR et al. Salmeterol: a potent and long-acting inhibitor of inflammatory mediator release from human lung. 1991 Br. J. Pharmacol. pmid:1724629
Misawa M and Kanai Y Effect of the new antiallergic drug epinastine on chemical mediator induced bronchoconstrictions in guinea pigs. 1991 Arzneimittelforschung pmid:1725697
Abman SH and Accurso FJ Sustained fetal pulmonary vasodilation with prolonged atrial natriuretic factor and GMP infusions. 1991 Am. J. Physiol. pmid:1847014
Sladek K et al. Formation of PGD2 after allergen inhalation in atopic asthmatics. 1991 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:1847781
King LS et al. Pulmonary vascular effects of prostaglandin D2, but not its systemic vascular or airway effects, are mediated through thromboxane receptor activation. 1991 Circ. Res. pmid:1825033
Marriott DR et al. Substance P-induced release of prostaglandins from astrocytes: regional specialisation and correlation with phosphoinositol metabolism. 1991 J. Neurochem. pmid:1702831
Smith GS et al. Adaptive cytoprotection against alcohol injury in the rat stomach is not due to increased prostanoid synthesis. 1991 Prostaglandins pmid:1906621
Conde B et al. Modulation of cell growth and differentiation induced by prostaglandin D2 in the glioma cell line C6. 1991 Jan-Feb Anticancer Res. pmid:1902073
Lundin-Schiller S and Mitchell MD Prostaglandin production by human chorion laeve cells in response to inflammatory mediators. 1991 Jul-Aug Placenta pmid:1946245
Naclerio RM Additional properties of cetirizine, a new H1 antagonist. 1991 May-Jun Allergy Proc pmid:1680095
van der Linden PW et al. Insect-sting challenge in 138 patients: relation between clinical severity of anaphylaxis and mast cell activation. 1992 J. Allergy Clin. Immunol. pmid:1629497
King KL et al. Metabolism of arachidonic acid by isolated rabbit ciliary epithelium. 1992 Exp. Eye Res. pmid:1426059
Thomas PS et al. Tobacco smoke releases performed mediators from canine mast cells and modulates prostaglandin production. 1992 Am. J. Physiol. pmid:1636731
Sasaguri T et al. Prostaglandins A and J arrest the cell cycle of cultured vascular smooth muscle cells without suppression of c-myc expression. 1992 Exp. Cell Res. pmid:1572402
Sinzinger H et al. Isradipine improves platelet function in hypertensives. 1992 Eur. J. Clin. Pharmacol. pmid:1531796
Ito S et al. Type-1 and type-2 astrocytes are distinct targets for prostaglandins D2, E2, and F2 alpha. 1992 Glia pmid:1324890
Tsukagoshi H and Kurosawa M [Bronchial hyperresponsiveness to histamine induced by intravenous administration of prostaglandin D2 (PGD2) in guinea pigs]. 1992 Nippon Yakurigaku Zasshi pmid:1559641
Magnussen H et al. Effects of a thromboxane-receptor antagonist, BAY u 3405, on prostaglandin D2- and exercise-induced bronchoconstriction. 1992 J. Allergy Clin. Immunol. pmid:1535083
Campbell AM et al. In vitro activation of bronchoalveolar lavage cells by house dust mite allergens. 1992 Ann Allergy pmid:1371209
Gaetani P et al. Ex vivo release of eicosanoids after aneurysmal subarachnoid hemorrhage: a preliminary experience in humans. 1992 Acta Neurol. Scand. pmid:1414230
Mitsuoka S et al. Inhibitory effect of prostaglandin delta 12-PGJ2 on cell proliferation and alpha-fetoprotein expression in HuH-7 human hepatoma cells. 1992 Prostaglandins pmid:1371888
Yen A et al. Protoporphyrin and long-wave ultraviolet light modulate metabolic events in rat peritoneal mast cells. 1992 J. Invest. Dermatol. pmid:1372341
Stellato C et al. Anti-inflammatory effect of cyclosporin A on human skin mast cells. 1992 J. Invest. Dermatol. pmid:1373749
Katz HR et al. Secretory granule mediator release and generation of oxidative metabolites of arachidonic acid via Fc-IgG receptor bridging in mouse mast cells. 1992 J. Immunol. pmid:1309842
Morrow JD et al. Identification of skin as a major site of prostaglandin D2 release following oral administration of niacin in humans. 1992 J. Invest. Dermatol. pmid:1373750
Okayama Y et al. Inhibition profiles of sodium cromoglycate and nedocromil sodium on mediator release from mast cells of human skin, lung, tonsil, adenoid and intestine. 1992 Clin. Exp. Allergy pmid:1375128
Okayama Y and Church MK Comparison of the modulatory effect of ketotifen, sodium cromoglycate, procaterol and salbutamol in human skin, lung and tonsil mast cells. 1992 Int. Arch. Allergy Immunol. pmid:1375203
Smith JB et al. Cyclic AMP does not inhibit collagen-induced platelet signal transduction. 1992 Biochem. J. pmid:1375452
Ikai K et al. Induction of 72-kD heat shock protein and cytoskeleton damage by cytotoxic prostaglandin delta 12-PGJ2 in transformed human epidermal cells in culture. 1992 J. Invest. Dermatol. pmid:1375619
Yu SM et al. Dicentrine, a novel antiplatelet agent inhibiting thromboxane formation and increasing the cyclic AMP level of rabbit platelets. 1992 Biochem. Pharmacol. pmid:1310852
Lippton HL et al. Mechanisms of signal transduction for adenosine and ATP in pulmonary vascular bed. 1992 Am. J. Physiol. pmid:1348400
Molderings G et al. Inhibition of noradrenaline release in the rat vena cava via prostanoid receptors of the EP3-subtype. 1992 Br. J. Pharmacol. pmid:1330175
Conti P et al. Role of lipoxins A4 and B4 in the generation of arachidonic acid metabolites by rat mast cells and their effect on [3H]serotonin release. 1992 Immunol. Lett. pmid:1612634
Raible DG et al. Mast cell mediators prostaglandin-D2 and histamine activate human eosinophils. 1992 J. Immunol. pmid:1588043
Amici C et al. Inhibition of Sendai virus replication by delta 12-prostaglandin J2: induction of heat shock protein synthesis and alteration of protein glycosylation. 1992 Antiviral Res. pmid:1332600
Seregi A et al. Functionally diverse purinergic P2Y-receptors mediate prostanoid synthesis in cultured rat astrocytes: the role of ATP-induced phosphatidyl-inositol breakdown. 1992 Eicosanoids pmid:1333251
Björnsson OG et al. Prostaglandins suppress VLDL secretion in primary rat hepatocyte cultures: relationships to hepatic calcium metabolism. 1992 J. Lipid Res. pmid:1331281
Knani J et al. Indirect evidence of nasal inflammation assessed by titration of inflammatory mediators and enumeration of cells in nasal secretions of patients with chronic rhinitis. 1992 J. Allergy Clin. Immunol. pmid:1334102
Stellato C et al. Human basophil/mast cell releasability. IX. Heterogeneity of the effects of opioids on mediator release. 1992 Anesthesiology pmid:1280014
de Paulis A et al. Anti-inflammatory effect of FK-506 on human skin mast cells. 1992 J. Invest. Dermatol. pmid:1281861
Tomita Y et al. Melanocyte-stimulating properties of arachidonic acid metabolites: possible role in postinflammatory pigmentation. 1992 Pigment Cell Res. pmid:1292020
Morii H and Watanabe Y A possible role of carbohydrate moieties in prostaglandin D2 and prostaglandin E2 receptor proteins from the porcine temporal cortex. 1992 Arch. Biochem. Biophys. pmid:1309289
Wang JP et al. Anti-inflammatory and analgesic effects of magnolol. 1992 Naunyn Schmiedebergs Arch. Pharmacol. pmid:1336574
Kuchinke W et al. A lung type prostaglandin F synthase is expressed in bovine liver: cDNA sequence and expression in E. coli. 1992 Biochem. Biophys. Res. Commun. pmid:1339268
Columbo M et al. The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils. 1992 J. Immunol. pmid:1378071
Goerg KJ et al. Inhibition of neuronally mediated secretion in rat colonic mucosa by prostaglandin D2. 1992 Gastroenterology pmid:1379954
Charlesworth EN et al. Effect of H1 receptor blockade on the early and late response to cutaneous allergen challenge. 1992 J. Pharmacol. Exp. Ther. pmid:1382132
Murakami M et al. Release of 14-kDa group-II phospholipase A2 from activated mast cells and its possible involvement in the regulation of the degranulation process. 1992 Eur. J. Biochem. pmid:1382985
Johnston SL et al. The effects of an oral thromboxane TP receptor antagonist BAY u 3405, on prostaglandin D2- and histamine-induced bronchoconstriction in asthma, and relationship to plasma drug concentrations. 1992 Br J Clin Pharmacol pmid:1467134
Lin CH et al. HA-29: an inhibitor of thromboxane A2 formation with antagonism of thromboxane A2/prostaglandin endoperoxide receptor in rabbit platelets. 1992 Thromb. Res. pmid:1412184
Koizumi T et al. Inhibitory effect of an intracellular glutathione on delta 12-prostaglandin J2-induced protein syntheses in porcine aortic endothelial cells. 1992 Biochem. Pharmacol. pmid:1417983
Norwitz ER et al. Prostaglandin D2 production by term human decidua: cellular origins defined using flow cytometry. 1992 Obstet Gynecol pmid:1495703
Sasaguri T et al. Anti-proliferative effect of prostaglandins A and J on cultured vascular smooth muscle cells. 1992 Jpn. J. Pharmacol. pmid:1507558
Hoshi A et al. [Experimental study on the role of prostaglandin D2 in the pathogenesis of bronchial asthma]. 1992 Nihon Kyobu Shikkan Gakkai Zasshi pmid:1507684
Bacic F et al. Prostaglandin D2 in cultured capillary and microvascular endothelium of human brain. 1992 Prostaglandins Leukot. Essent. Fatty Acids pmid:1508957
Thomas PS et al. Prostaglandin D2 production and identification of prostaglandin H synthase within canine mast cell granule. 1992 Am. J. Physiol. pmid:1514641
Kaiser L et al. Dirofilaria immitis: do filarial cyclooxygenase products depress endothelium-dependent relaxation in the in vitro rat aorta? 1992 Exp. Parasitol. pmid:1516664
Braun M and Schrör K Prostaglandin D2 relaxes bovine coronary arteries by endothelium-dependent nitric oxide-mediated cGMP formation. 1992 Circ. Res. pmid:1385004
Goto H et al. Age-associated decreases in prostaglandin contents in human gastric mucosa. 1992 Biochem. Biophys. Res. Commun. pmid:1510674
Emery BE et al. The effect of IL-4 on human nasal mucosal responses. 1992 J. Allergy Clin. Immunol. pmid:1430703
Barrett KE Effect of histamine and other mast cell mediators on T84 epithelial cells. 1992 Ann. N. Y. Acad. Sci. pmid:1456653
Tamaoki J et al. Prostaglandin D2 increases Cl secretion across canine tracheal epithelium through cyclo-oxygenase stimulation and cAMP production. 1992 Acta Physiol. Scand. pmid:1323920
Froldi M et al. Mediator release in cerebrospinal fluid of human immunodeficiency virus-positive patients with central nervous system involvement. 1992 J. Neuroimmunol. pmid:1315794
Fukushima M Biological activities and mechanisms of action of PGJ2 and related compounds: an update. 1992 Prostaglandins Leukot. Essent. Fatty Acids pmid:1438462
Shimakura S and Boland CR Eicosanoid production by the human gastric cancer cell line AGS and its relation to cell growth. 1992 Cancer Res. pmid:1551103
Ninomiya H et al. Endothelin-1 induces stimulation of prostaglandin synthesis in cells obtained from canine airways by bronchoalveolar lavage. 1992 Prostaglandins pmid:1584994
Lee DY et al. Prostaglandin profile and synthetic capacity of the colon: comparison of tissue sources and subcellular fractions. 1992 Prostaglandins pmid:1542741
Picado C et al. Release of peptide leukotriene into nasal secretions after local instillation of aspirin in aspirin-sensitive asthmatic patients. 1992 Am. Rev. Respir. Dis. pmid:1309968
Kawada N et al. Possible induction of fatty acid cyclo-oxygenase in lipopolysaccharide-stimulated rat Kupffer cells. 1992 Gastroenterology pmid:1499903
Koizumi T et al. Induction of heme oxygenase by delta 12-prostaglandin J2 in porcine aortic endothelial cells. 1992 Prostaglandins pmid:1542739
Eguchi N et al. Permeability of brain structures and other peripheral tissues to prostaglandins D2, E2 and F2 alpha in rats. 1992 J. Pharmacol. Exp. Ther. pmid:1527717
Rangachari PK Concerning prostaglandin D2: forgotten, promiscuous, capricious. 1992 Ann. N. Y. Acad. Sci. pmid:1456655
Krueger JM et al. Prostaglandins E2 and D2 have little effect on rabbit sleep. 1992 Physiol. Behav. pmid:1523224
D'Onofrio C et al. Comparative anti-viral and anti-proliferative activity of PGA1 and PGJ2 against HTLV-I-infected MT-2 cells. 1992 Int. J. Cancer pmid:1592539
Wang D et al. Terbutaline acts at multiple sites to inhibit bronchoconstriction induced by dry air in canine peripheral airways. 1992 Am. Rev. Respir. Dis. pmid:1595994
Hogaboam CM et al. Platelet-activating factor synthesis by peritoneal mast cells and its inhibition by two quinoline-based compounds. 1992 Br. J. Pharmacol. pmid:1596692